Clinical Trial Update: Randomized Study Comparing Endeavor With Cypher Stents (PROTECT) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the Endeavor zotarolimus-eluting stent with the Cypher sirolimus-eluting stent in patients with ischemic heart disease; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• Cypher Sirolimus-Eluting Stent (sirolimus-eluting stent)
• Endeavor zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: Medtronic Vascular | Conditions: Ischemic Heart Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-03-17